Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5994
Title: Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres
Authors: Yuen, Michaela
Cooper, Sandra T
Marston, Steve B
Nowak, Kristen J
McNamara, Elyshia
Mokbel, Nancy
Ilkovski, Biljana
Ravenscroft, Gianina
Rendu, John
de Winter, Josine M
Klinge, Lars
Beggs, Alan H
North, Kathryn N
Ottenheijm, Coen A C
Clarke, Nigel F
Affiliations: Faculty of Health Sciences 
Issue Date: 2015-01-15
Part of: Human Molecular Genetics
Volume: 24
Issue: 22
Start page: 6278
End page: 6292
Abstract: 
Dominant mutations in TPM3, encoding α-tropomyosinslow, cause a congenital myopathy characterized by generalized muscle weakness. Here, we used a multidisciplinary approach to investigate the mechanism of muscle dysfunction in 12 TPM3-myopathy patients. We confirm that slow myofibre hypotrophy is a diagnostic hallmark of TPM3-myopathy, and is commonly accompanied by skewing of fibre-type ratios (either slow or fast fibre predominance). Patient muscle contained normal ratios of the three tropomyosin isoforms and normal fibre-type expression of myosins and troponins. Using 2D-PAGE, we demonstrate that mutant α-tropomyosinslow was expressed, suggesting muscle dysfunction is due to a dominant-negative effect of mutant protein on muscle contraction. Molecular modelling suggested mutant α-tropomyosinslow likely impacts actin-tropomyosin interactions and, indeed, co-sedimentation assays showed reduced binding of mutant α-tropomyosinslow (R168C) to filamentous actin. Single fibre contractility studies of patient myofibres revealed marked slow myofibre specific abnormalities. At saturating [Ca(2+)] (pCa 4.5), patient slow fibres produced only 63% of the contractile force produced in control slow fibres and had reduced acto-myosin cross-bridge cycling kinetics. Importantly, due to reduced Ca(2+)-sensitivity, at sub-saturating [Ca(2+)] (pCa 6, levels typically released during in vivo contraction) patient slow fibres produced only 26% of the force generated by control slow fibres. Thus, weakness in TPM3-myopathy patients can be directly attributed to reduced slow fibre force at physiological [Ca(2+)], and impaired acto-myosin cross-bridge cycling kinetics. Fast myofibres are spared; however, they appear to be unable to compensate for slow fibre dysfunction. Abnormal Ca(2+)-sensitivity in TPM3-myopathy patients suggests Ca(2+)-sensitizing drugs may represent a useful treatment for this condition.
URI: https://scholarhub.balamand.edu.lb/handle/uob/5994
ISSN: 09646906
DOI: 10.1093/hmg/ddv334
Open URL: Link to full text
Type: Journal Article
Appears in Collections:Department of Medical Laboratory Sciences

Show full item record

SCOPUSTM   
Citations

28
checked on Dec 3, 2022

Record view(s)

6
checked on Dec 7, 2022

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.